Raj Kannan - 20 Dec 2021 Form 4 Insider Report for AERIE PHARMACEUTICALS INC

Role
Chief Executive Officer, Director
Signature
/s/ Raj Kannan
Issuer symbol
N/A
Transactions as of
20 Dec 2021
Net transactions value
$0
Form type
4
Filing time
22 Dec 2021, 19:07:30 UTC
Previous filing
05 Aug 2021
Next filing
22 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AERI Common Stock Award $0 +215,783 $0.000000 215,783 20 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AERI Stock Option (right to buy) Award $0 +387,169 $0.000000 387,169 20 Dec 2021 Common Stock 387,169 $8.11 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of December 20, 2021.
F2 This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on December 20, 2022 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of December 20, 2022.